ENT Devices Global Market Report 2024

The ent devices market size has grown strongly in recent years. It will grow from $32.89 billion in 2023 to $35.81 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth experienced during the historical period can be attributed to several key factors, including an aging population, the prevalence of chronic health conditions, developments in healthcare reimbursement, and advancements in diagnostic technologies.

The ent devices market size is expected to see strong growth in the next few years. It will grow to $49.23 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be attributed to various factors, including the increasing adoption of telemedicine and remote consultations, the advancement of personalized medicine, the shift towards value-based healthcare, the expansion of emerging markets, and the integration of artificial intelligence (AI) in healthcare. Key trends in the forecast period encompass minimally invasive medical procedures, remote monitoring and telehealth services, 3D printing of urological implants, tele-audiology, and the development of smart hearing protection solutions.

The growth of the ENT device market is expected to be driven by the rising incidence of ENT disorders. ENT, which stands for Ear, Nose, and Throat, encompasses a wide range of medical conditions affecting these areas of the body. ENT devices are utilized for the purpose of diagnosing, monitoring, and addressing these health conditions. According to a World Health Organization article from February 2023, more than 5% of the global population, equivalent to 430 million individuals (comprising 432 million adults and 34 million children), will require rehabilitation due to significant hearing impairment. Furthermore, it is anticipated that the number of people with hearing loss will surpass 700 million by the year 2050. As a result, the increasing prevalence of ENT disorders is set to drive the growth of the ENT device market in the foreseeable future.

These ENT devices encompass a range of categories, including hearing aid devices and equipment, hearing diagnostic devices and equipment, ENT surgical devices and equipment, hearing implants, voice prosthesis devices and equipment, and nasal splints. A hearing aid device, for instance, is an electronic apparatus designed to be worn either in or behind the ear. Its purpose is to amplify sounds, thus enabling individuals with hearing impairments to effectively engage in daily activities, communicate, and participate in various interactions. These devices can be procured through either public or private funding, and they involve the use of instruments/equipment and disposable components. The key end-users of these ENT devices are typically hospitals, clinics, diagnostic laboratories, and other medical facilities.

The ENT devices market research report is one of a series of new reports that provides ENT devices market statistics, including ENT devices industry global market size, regional shares, competitors with an ENT devices market share, detailed ENT devices market segments, market trends and opportunities, and any further data you may need to thrive in the ENT devices industry. This ENT devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Governments worldwide have implemented new healthcare acts and consistently raised healthcare expenditures, resulting in expanded healthcare coverage and increased spending. As an illustration, in 2021, the Indian government initiated the Ayushman Bharat PradhanMantri Jan Arogya Yojana (AB-PMJAY), which offers health assurance coverage of up to ₹5 lakh per year per family for secondary and tertiary healthcare hospitalizations. These favorable governmental initiatives and heightened healthcare investments have led to an upsurge in the demand for healthcare services, consequently driving the demand for ENT devices during this period.

Anticipated global increases in interest rates across many developing and developed economies during the forecast period are expected to constrain new investments within the market. Several countries worldwide are opting to raise interest rates to manage inflation and curb the outflow of capital from their economies. This trend is likely to impact new investments, hindering expansion initiatives and research and development efforts for new products. As an illustration, the United States is projected to witness interest rates climbing to 3.5% by 2021. These developments are poised to exert a detrimental influence on the market, given that borrowing funds becomes more expensive, subsequently affecting market growth.

Prominent companies in the ENT devices market are driving innovation by introducing new technologies like TruDi, aimed at enhancing their market profitability. TruDi is an advanced ENT navigation system that delivers dependable and efficient image-guided preoperative planning and navigation for ENT procedures. For example, in January 2022, Acclarent Inc., a subsidiary of Johnson & Johnson Medical Devices Companies based in the United States, unveiled an AI-powered ENT technology known as TruDi. This software package comprises TruSeg and TruPath, developed for use with the TruDi Navigation System. It leverages a machine learning algorithm to provide reliable and effective image-guided preoperative planning and navigation for ear, nose, and throat (ENT) procedures, such as endoscopic sinus surgery. The TruDi Navigation System itself is an innovative single-use electromagnetically guided blade designed for ENT procedures.

ENT device manufacturers are actively investing in cutting-edge technologies to create more user-friendly and minimally invasive equipment. Substantial financial and resource investments are channeled into research and development efforts to expand the capabilities of their devices. For example, Intersect ENT, a healthcare equipment company based in the United States, engineered the Propel Mometasone Furoate Implant (PMFI) for the treatment of chronic sinusitis. This bio-absorbable steroid implant is directly placed into the sinus mucosa, enabling controlled drug release and gradual dissolving over time. Additionally, SinuSys Corporation, a U.S.-based pharmaceutical firm, secured FDA approval for its Vent-Os Sinus Dilation device, a small, low-pressure insert designed to gently open sinus ostia and leverage the body's natural mucosal fluids for device expansion.

Major companies operating in the ent devices market include Sonova Holdings AG, Demant A/S, Medtronic PLC, GN Store Nord A/S, Cochlear Limited, Olympus Corporation, Stryker Corporation, Karl Storz SE & Co. KG, Merck & Co. Inc., Smith & Nephew PLC, Richard Wolf GmbH, Cook Group Incorporated, Grace Medical Inc., Intersect ENT Inc., Lumenis Ltd., Merz Pharma GmbH & Co KGaA, Atos Medical AB, Oticon Medical AB, Siemens Healthcare GmbH, ArthroCare Corporation, Xoran Technologies LLC, Zhejiang Tiansong Medical Instrument Co. Ltd., Acclarent Inc., Meril Life Sciences Pvt. Ltd., SinuSys Corporation, Audina Hearing Instruments Inc., Ambu A/S, Nupur Technologies, 3NT Medical, Welch Allyn Inc., Otopront Medizintechnik GmbH.

Asia-Pacific was the largest region in the global ENT devices market in 2023. North America was the second largest region in the global ENT devices market. Africa. was the smallest region in the global ENT devices market. The regions covered in the ENT devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the ent devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The ENT devices market consists of sales of instruments such as Pure tone and impedance audiometers, BERA and OAE screening machines, nerve stimulators, and high-end microdrill that are used for diagnosis and treatment of ENT diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.